Welcome to our dedicated page for RCM TECHNOLOGIES SEC filings (Ticker: RCMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RCM Technologies, Inc. filings document the reporting obligations of a Nevada-incorporated operating company with common stock registered on Nasdaq under the symbol RCMT. Its Form 8-K reports cover financial results, material agreements, revolving credit and loan amendments, direct financial obligations, changes in certifying accountants, and related internal control disclosures.
The company’s proxy materials address board matters, executive compensation, equity award information, and pay-versus-performance disclosure. Periodic and notice filings provide formal records around annual reporting, late-filing notifications, consolidated financial statements, risk and control matters, and the governance framework supporting RCM Technologies’ health care, engineering, information technology, life sciences, data, and solutions services.
Bradley S. Vizi, Executive Chairman and President of RCM Technologies (RCMT), reported routine insider sales under a pre-established Rule 10b5-1 plan. The Form 4 discloses three non-discretionary sales executed on 09/17/2025, 09/18/2025 and 09/19/2025 for aggregate reductions from his holdings: after the 09/17 sale he beneficially owned 1,519,036 shares, after 09/18 he owned 1,516,416 shares, and after 09/19 he owned 1,512,591 shares. The reported sale prices are reported as weighted averages in the $27.50–$27.595 ranges. The filing is a disclosure of executed sales under a December 7, 2023 plan and does not provide additional commentary.
RCM Technologies insider Bradley Vizi, Executive Chairman & President, reported three routine sales of common stock in early September 2025 under a pre-established Rule 10b5-1 trading plan. The filings show dispositions of 4,508 shares on 09/05/2025 at a weighted average price near $27.50, 3,961 shares on 09/08/2025 at a weighted average near $27.51, and 4 shares on 09/09/2025 at $27.50. Following these transactions, Mr. Vizi beneficially owned 1,522,805 shares (direct). The Form 4 notes the sales were nondiscretionary under a plan established December 7, 2023.
Bradley S. Vizi, who serves as Executive Chairman & President and is a director and 10% owner of RCM Technologies, Inc. (RCMT), reported a sale of 673 shares of the issuer's common stock on 08/29/2025 at a reported price of $27.50 per share. The sale was made pursuant to a nondiscretionary plan established by the reporting person on December 7, 2023 intended to satisfy Rule 10b5-1 affirmative defense conditions. Following the reported transaction, the reporting person beneficially owns 1,531,278 shares in a direct capacity. The Form 4 is signed by Bradley S. Vizi dated 09/03/2025.
Bradley S. Vizi, Executive Chairman & President of RCM Technologies, Inc. (RCMT), reported a non-derivative sale of common stock on 08/26/2025. The Form 4 shows a sale of 7,289 shares at $27.51 per share executed under a nondiscretionary plan established on December 7, 2023 to satisfy Rule 10b5-1 requirements. After the sale, the reporting person beneficially owned 1,531,951 shares. The filing identifies Mr. Vizi as a director and a greater-than-10% owner. No derivative transactions are reported on this form.
Michael Saks, Division President, Healthcare Services at RCM Technologies, reported a sale of 5,000 shares of RCM Technologies common stock on 08/26/2025 at a reported price of $27.50 per share. After the transaction, the filing shows the reporting person beneficially owns 109,547 shares. The filing also notes 393 shares were acquired under the issuer's Employee Stock Purchase Plan since the most recent Section 16 filing.
The sale is reported as a nondiscretionary transaction executed under a plan established to satisfy Rule 10b5-1 requirements, indicating the disposition followed a prearranged plan rather than an ad hoc decision. The Form 4 lists the reporting person as an officer of the company and is filed by one reporting person.
RCM Technologies (RCMT) submitted a Form 144 reporting a proposed sale of 260,856 shares of common stock through Baird on the NASDAQ with an aggregate market value of $6,850,000. The filing lists 7,410,510 shares outstanding, and the securities to be sold were acquired as restricted share vesting under equity compensation on 01/15/2021 (125,000), 01/03/2023 (125,000) and 01/16/2023 (50,000). The filer reports no sales in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information.
RCM Technologies (RCMT) files a Form 144 reporting a proposed sale of 5,000 shares of common stock, with an aggregate market value of $137,500, to be sold approximately on 08/26/2025 on NASDAQ. The filing shows the shares were acquired through the company’s Employee Stock Purchase Plan on six dates between 2014 and 2022 and the listed acquisition lot quantities sum to 5,000 shares. No securities of the issuer were reported sold by the filer in the past three months. The notice includes the filer’s representation that they are not aware of undisclosed material adverse information about the issuer.